# GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

> **NCT06017544** · — · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 257 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Myocardial Infarction

## Interventions

- **PROCEDURE:** PCI

## Key facts

- **NCT ID:** NCT06017544
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06017544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06017544, "GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06017544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*